Plasma C3a-des-Arg levels in women with and without endometriosis

American Journal of Reproductive Immunology

Volumn 62, Issue 3, 2009, Pages 187-195

  Fassbender, Amelie ^a   D'Hooghe, Thomas ^a   Mihalyi, Attila ^a   Kyama, Cleophas ^a   Simsa, Peter ^a   Lessey, Bruce A ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b University Medical Group   (United States)

Author keywords

Anaphylatoxin; Complement; Non invasive diagnostic test

Indexed keywords

ARGININE; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A; DIETHYLSTILBESTROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANAPHYLATOXINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMPLEMENT C3A; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED;

EID: 69149091102     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00728.x     Document Type: Article

References (59)

1. Berkkanoglu M, Arici A: Immunology and endometriosis. Am J Reprod Immunol 2003; 50:48-59.
2. Kyama CM, Mihalyi A, Simsa P, Mwenda JM, Tomassetti C, Meuleman C, D'Hooghe TM: Nonhormonal targets in the diagnosis and treatment of endometriosis. Curr Med Chem 2008; 15:1006-1017.
3. Hadfield R, Mardon H, Barlow D, Kennedy S: Delay in the diagnosis of endometriosis: A survey of women from USA and the UK. Hum Reprod 1996; 11:878-880.
4. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E: ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20:2698-2704.
5. Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, Fontana S, Lechler RI, Bloom SR, De Placido G: Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab 2000; 85:2483-2487.
6. Gupta S, Agarwal A, sekhon L, Krajcir N, Cocuzza M, Falcone T: Serum and peritoneal abnormalities in endometriosis: Potential use as diagnostic markers. Minerva Ginecol 2006; 58:527-551.
7. D'Hooghe TM, Debrock S: Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 2002; 8:84-88.
8. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A: Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 2002; 17:426-431.
9. Gazvani R, Templeton A: Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002; 123:217-226.
10. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D: Is endometriosis associated with subclinical pelvic inflammation. Gynecol Obstet Invest 2006; 62:139-147.
11. Mihalyi A, Gevaert O, Kyama C, Simsa P, Pochet N, De Smet F, De Moor B, Meuleman C, Billen J, Blanckaert N, Vodolazkaia A, Fulop V, D'Hooghe T: Diagnosis of minimal-mild endometriosis with high sensitivity after combined analysis of plasma levels of IL-6, IL-8, TNF-α, CA 125, CA 19-9 and CRP, presented at SGI meeting 2006, Toronto, Canada. J Soc Gynecol Invest 2006; 13(Suppl. 2):494 (Poster).
12. Holers VM: Complement as a regulatory and effector pathway in human diseases. In Therapeutic Intervention in the Complement System, JD Lambris, VM Holers (eds). Towota, NJ, Humana Press, 2000, pp 12-21.
13. Davies KA, Walport MJ: Processing and clearance of the immune complexes by complement and the role of complement in immune complex diseases. In The Human Complement System in Health and Disease, JE Volanakis, MM Frank (eds). New York, Marcel Dekkerm, 1998, pp 423-452.
14. Markiewski MM, Mastellos D, Tudoan R, DeAngelis RA, Strey CW, Franchchini S, Wetsel RA, Erdei A, Lambris JD: C3a and C3b activation products of the third component of complement (C3) are critical for normal lover recovery after toxic injury. J Immunol 2004; 173:747-754.
15. Kacani L, Banki Z, Zwirner J, Schennach H, Bajtay Z, Erdeu A, Stoiber H, Dierich MP: C5a and C5a-des-Arg enhance the susceptibility of monocyte-derived macrophages to HIV infection. J Immunol 2001; 166:3410-3415.
16. D'Hooghe TM, Hill JA: Is endometriosis an autoimmunological disease? In Immunology of Reproduction, M Kurpisz, N Fernandez (eds). Oxford, Oxford University Press, 1995, pp 133-162.
17. Cichon G, Boeckh-Herwig S, Schmidt HH, Whnes E, Müller T, Pring-Akerblom P, Burger R: Complement activation by recombinant adenoviruses. Gene Ther 2001; 8:1794-1800.
18. Saifuddin A, Buckley CH, Fox H: Immunoglobulin content of the endometrium in women with endometrium. Int J Gynecol Pathol 1983; 2:255-258.
19. Badawy SZA, Cuenca V, Stitzel A, Jacobs RD, Tomar RH: Autoimmune phenomena in infertile patients with endometriosis. Obstet Gynecol 1984; 63:271-275.
20. Wild RA, Shivers CA: Antiendometrial antibodies in patients with endometriosis. Am J Reprod Immunol 1985; 8:84-85.
21. Bartosik D, Damjanov I, Viscarello RR, Riley JA: Immunoproteins in endometrium, clinical correlates of the presence of complement fraction C3 and C4. Am J Obstet Gynecol 1987; 156:11-15.
22. Kreiner D, Fromowotz FB, Smith SSK: Endometrial immunofluorescence associated with endometriosis and pelvic infection. Fertil Steril 1986; 46:243-246.
23. Meek SC, Hodge DD, Musich JR: Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol 1988; 158:1365-1373.
24. Weed JC, Crquembourg PC: Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980; 23:885-893.
25. Holers VM, Thurmann JM: The alternative pathway of complement in disease: Opportunities for therapeutic targeting. Mol Immunol 2004; 41:147-152.
26. Zipfel PF, Heinen D, Jozsi M, Serka C: Complement and disease: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43:97-106.
27. Kabut J, Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A: Levels of complement components iC3b, C3c, C4 and SC5b-9 in peritoneal fluid and serum of infertile women and endometriosis. Fertil Steril 2007; 88:1298-1303.
28. Humbles AA, Lu B, Nilsson CA, Lilly C, Isreal E, Fujiwara Y, Gerard NP, Gerard C: A role of the C3a anaphzlatoxin receptor in the effector phase of asthma. Nature 2000; 406:998-1001.
29. Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril 2001; 75:1-10.
30. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM: Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003; 1:123.
31. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H: Immunopathogenesis of pelvRc endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol 2008; 60:383-404.
32. Kamer-Bartosińska A, Szyłło K, Tchórzewski H, Lewy J: Innate immunity participation in the pathogenesis of endometriosis. Ginekol Pol 2003; 74:959-967.
33. Steele RW, Dmowski WP, Marmer DJ: Immunologic aspects of endometriosis. Am J Reprod Immunol 1984; 6:33-36.
34. Taylor PV, Maloney MD, Campbell JM, Skerrow SM, Nip MM, Parmar R, Tate G: Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991; 98:680-684.
35. Ota H, Maki M, Shidara Y, Kodama H, Takahashi H, Hayakawa M, Fujimori R, Kushima T, Ohtomo K: Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: A multi-center cooperative study. Am J Obstet Gynecol 1992; 167:481-486.
36. Giradi G, Salmon JE: The role of complement in pregnancy and fetal loss in the book. In The Complement System: Novel Roles in Health and Disease, Janos Szebeni (eds). Norwell, Kluwer Academic Publishers, 2004, pp 187-199.
37. Isaacson KB, Coutifaris C, Garcia CR, Lyttle CR: Production and secretion of complement component 3 by endometriotic tissue. J Clin Endocrinol Metab 1989; 69:1003.
38. Isaacson KB, Galman M, Coutifaris C, Lyttle CR: Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril 1990; 53:836-841.
39. Isaacson KB, Xu Q, Lyttle CR: The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue. Fertil Steril 1991; 55:395.
40. Sayegh RA, Tao XJ, Awwad JT, Isaacson KB: Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. J Clin Endocrinol Metab 1996; 81:1641.
41. Tao XJ, Sayegh RA, Isaacson KB: Increased expression of complement component 3 in human ectopic endometrium compared with the matched eutopic endometrium. Fertil Steril 1997; 68:460.
42. Wei Q, St Clair JB, Fu T, Stratton P, Nieman LK: Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril, 2009; 91:1686-1691.
43. Odagiri K, Konno R, Fujiwara H, Netsu S, Ohwada M, Shibahara H, Suzuki M: Immunohistochemical study of osteopontin and L-selectin in a rat endometriosis model and in human endometriosis. Fertil Steril 2007; 88:1207-1211.
44. Lessey BA: Implantation defects in infertile women with endometriosis. Ann N Y Acad Sci 2002; 955:265-280; discussion pp 293-295, 396-406.
45. Böhler J, Donauer K, Köster W, Schollmeyer PJ, Wieland H, Hörl WH: Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia. Am J Nephrol 1991; 11:479-485.
46. American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1997; 67:817-821.
47. Wust SK, Blumenthal MN, Corazalla EO, Benson BA, Dalmasso AP: Complement in asthma: Sensitivity to activation and generation of C3a and C5a via the different complement pathways. Transl Res 2006; 148:157-163.
48. Fentz AK, Spörl M, Spangenberg J, List HJ, Zornig C, Dörner A, Layer P, Juhl H, David KA: Detection of colorectal adenoma and cancer based on transthyretin and C3a-des-Arg serum levels. Proteomics 2007; 1:536-544.
49. Schoemaker RC, Giclas PC, Crowder C, House D, Glovsky MM: Complement split products C3a and C4a are early markers of acute lyme disease in thick bite patients in the United States. Int Arch Allergy Immunol 2008; 146:255-261.
50. Sivaprasad S, Adewoyin T, Bailey TA, Dandekar SS, Jenkins S, Webster AR, Chong NV: Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol 2007; 125:515-519.
51. Lee SH, Rhim T, Choi YS, Min JW, Kim SH, Cho SY, Paik YK, Park CS: Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006; 173:370-378.
52. Habermann JK, Roblick UJ, Luke BT, Prieto DA, Finlay WJ, Podust VN, Roman JM, Oevermann E, Schiedeck T, Homann N, Duchrow M, Conrads TP, Veenstra TD, Burt SK, Bruch HP, Auer G, Ried TR: Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology 2006; 131:1020-1029.
53. Girardi G, Patricia Redecha P, Salmon JE: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10:1222-1226.
54. Loeffler DA: Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease. Neurobiol Aging 1997; 18:555-557.
55. Campo A, Hausmann G, Martí RM, Estrach T, Grau JM, Porcel JM, Herrero C: Complement activation products (C3a and C5b-9) as markers of activity of dermatomyositis Comparison with usual biochemical parameters. Actas Dermosifiliogr 2007; 98:403-414.
56. Terui T, Takematsu H, Kato T, Ohkohchi K, Tagami H: Plasma anaphylatoxin concentrations in inflammatory skin diseases. Tohoku J Exp Med 1987; 151:245-252.
57. Okroj M, Heinegard D, Holmdahl R, Blom AM: Rheumatoid arthritis and the complement system. Ann Med 2007; 39:517-530.
58. Moxley G, Ruddy S: Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 1985; 28:1089-1095.
59. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, Ismail T, Wakelam MJO, Johnson PJ, Martin A: Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006; 94:1898-1905.